MaxCyte competitors

Experienced public company CEO determined to leave the world a healthier place than when he arrived by developing new treatments for serious diseases and conditions.

George McGovern is a Chairman/CEO at HEALTH DISCOVERY CORP. He has worked as Board Member at HEALTH DISCOVERY CORP.

Geoff is a pioneer in cell and gene therapy with a track record of successful leadership at innovative biotechs. He is the former CEO of Organogenesis Inc., the world’s leading cell therapy company. During his tenure at the helm, the company treated 1 million patients with living cell therapies, received the first approval of an allogeneic cell therapy from the FDA’s Center for Biologics Evaluation and Research and led the field of regenerative medicine. Geoff is also the founding CEO of eGenesis, a biotech dedicated to applying CRISPR Cas-9 gene editing to xenotransplantation. Earlier in his career, Geoff spent 11 years at Novartis in senior leadership positions within the global transplantation and immunology franchise. Geoff sits on the boards of Talaris Therapeutics and Satellos Bioscience. Past activities include chairman of the board of MassBio, chairman of the board of the Alliance of Regenerative Medicine, and a member of the advisory council to the Health Policy Commission for Massachusetts.

Ramkumar Mandalam is a President/CEO at Cellerant Therapeutics Inc, Board Member at Cellerant Therapeutics Inc, and Board Member at Cryoport. He has experience at VERICEL CORP. Ramkumar attended University of Michigan.

Cynthia Bamdad is a CEO at Minerva Biotechnologies and is based in Boston, Massachusetts. She has worked as Director at Pharmacyclics and CSO Clinical Micro Sensors, now Genmark at Minerva Biotechnologies. Cynthia works or has worked as BOARD MEMBER at Schl of Social Science, BOARD MEMBER at Urban Affairs and Public Policy, and BOARD MEMBER at Northeastern University. She attended Harvard University between 1992 and 1997 and Northeastern University.

Mike Tomas is a Chair:Glbl Entrepreneurship Center at Florida International University - FIU, Board Member at Easy Solutions Inc, and Board Member at Total Home Health and is based in เขตเมืองไมอามี่/ฟอร์ต ลอเดอร์เดล สหรัฐอเมริกา. He has worked as President at Astri Group; Chief Marketing Officer at Avantel; and President/CEO/CFO at U.S. STEM CELL, INC.. Mike works or has worked at MCI INC and works or has worked as MEMBER at University of Miami's, CHAIRMAN at Florida International University - FIU, and Chief Marketing Ofcr:Avantel at MCI INC. He studied at Miami Dade College, Florida International University - FIU, and University of Miami.

Hiroki Tomohisa is a Chief Executive Officer at Takara Bio Usa Inc. and is based in Le Pecq, Yvelines Department, France. He has worked as Project Manager, Manufacturing Transfer at Takara Bio Usa Inc.; President at Takara Bio Usa Inc.; and International Business Manager at Takara Bio Usa Inc.. Hiroki attended Okayama University between 1997 and 1999; The Open University between 2010 and 2014; and University of California, Davis, University Extension between 1999 and 2000.